Pfizer/BioNTech request full FDA approval of COVID-19 booster vaccine
Fox News
Pfizer/BioNTech have initiated an application for full FDA approval of its COVID-19 vaccine booster shot for individuals aged 16 and up, the companies announced Wednesday, noting an expected completion by the end of the week.
Side effects within a week after the booster were mild-to-moderate, the companies said, with most frequent side effects including "injection site pain, fatigue, headache, muscle and joint pain, and chills," similar to the second dose of the primary series.More Related News
'If the shoe fits': Origin stories behind popular expressions, plus our newest American Culture Quiz
The Fox News Lifestyle Newsletter brings you trending stories on family, travel, food, neighbors helping neighbors, pets, autos, military veterans, heroes, faith and American values.